Medical News Today: Lymphoma/Leukemia News

Syndicate content
Leukemia is a cancer of the blood cells, usually affecting the white blood cells, which causes these cells to not work properly. There are four main types of leukemia. Lymphoma is a type of cancer that originates in the lymphatic system. There are two main types of lymphoma. Multiple myeloma is a type of cancer that affects certain white blood cells called plasma cells.
Updated: 2 hours 59 min ago

Skin cancer and rashes: Cancerous and precancerous lesions

August 22, 2017 - 07:00
A rash can be a sign of skin cancer. Find out the differences between cancerous and non-cancerous rashes, and the types of cancer that cause them.

Vitamin C may stop leukemia from progressing

August 17, 2017 - 16:00
New research finds that high-dose vitamin C can genetically 'reprogram' leukemic cells to mature and die normally, instead of replicating to cause cancer.

Leukemia: Mushroom protein could be used in future treatments

August 13, 2017 - 07:00
A protein found in the edible mushroom commonly known as "shaggy ink cap" has the potential to kill leukemia T cells, a new study suggests.

Drug hope for acute myeloid leukaemia

August 11, 2017 - 07:00
A new drug that strips cancer cells of their "immortality" could help to treat patients suffering from one of the most aggressive forms of leukaemia.

FDA approves first treatment for certain types of poor-prognosis acute myeloid leukemia

August 4, 2017 - 13:00
The U.S. Food and Drug Administration has approved Vyxeos for the treatment of adults with two types of acute myeloid leukemia (AML): newly diagnosed therapy-related AML (t-AML) or AML with...

Leukemia breakthrough: Blood molecule key to treating AML

August 4, 2017 - 07:00
Heme, a chemical structure found in hemoglobin, is key to treating acute myeloid leukemia, an aggressive form of blood cancer, researchers have discovered.

FDA approves new targeted treatment for relapsed or refractory acute myeloid leukemia

August 2, 2017 - 13:00
The U.S. Food and Drug Administration has approved Idhifa (enasidenib) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic...

Cell mechanism discovery could lead to 'fundamental' change in leukemia treatment

July 31, 2017 - 07:00
Researchers have identified a new cell mechanism that could lead to a fundamental change in the diagnosis and treatment of leukaemia.

Scientists make breakthrough in reversing treatment resistance in blood cancer patients

July 19, 2017 - 07:00
Researchers from the University of Southampton have identified why some people may become resistant to monoclonal antibodies, a common type of immunotherapy used in lymphoma treatment.

CAR T-cell therapy for leukemia leads to remissions in clinical trial

July 19, 2017 - 07:00
Researchers at Fred Hutchinson Cancer Research Center showed about 70 percent of patients with the most common adult leukemia had their tumors shrink or disappear following an experimental chimeric...

Human antibody bolsters cancer drug performance

July 1, 2017 - 07:00
Some patients do not respond to the cancer drug rituximab, but breaking research finds that the addition of a human antibody reduces this resistance.

The gene behind follicular lymphoma

June 29, 2017 - 13:00
EPFL scientists have discovered an important gene whose loss lies behind follicular lymphoma, an incurable cancer.

New antibody uses one-two punch to potentially treat blood cancers

June 27, 2017 - 07:00
Researchers have developed a two-pronged approach to blood cancer treatment: 1) attacking cancer cells directly and/or 2) driving them from the nurturing bone marrow environment into the peripheral...

Protein network signals found to drive myeloid leukemias

June 16, 2017 - 07:00
Researchers have uncovered how mutations in a protein network drive several high-risk leukemias, offering new prospects for novel therapies.

Precision therapy enasidenib effective in treating deadly form of leukemia

June 12, 2017 - 07:00
Some patients with relapsed or treatment-resistant acute myeloid leukemia, a form of blood cancer for which there are few treatments, may achieve remission with an experimental targeted therapy...

Cannabinoids and chemotherapy in combination kill cancer cells

June 7, 2017 - 07:00
Certain chemicals in cannabis have a potent leukemia-fighting prowess. New research shows that the key to killing cancer is the combination and order.

Study leads to breakthrough in better understanding acute myeloid leukemia

May 24, 2017 - 16:00
A study led by the University of Birmingham has made a breakthrough in the understanding of how different genetic mutations cause acute myeloid leukaemia.

New test more effective at predicting survival in blood cancer patients

May 11, 2017 - 07:00
Technology that can detect the length of small DNA structures in cancer cells could hold the key to predicting the outcome of patients with two different types of blood cancer.

Hodgkin lymphoma survivors have more severe coronary artery disease post chest irradiation

May 9, 2017 - 07:00
Findings support argument for coronary artery disease screening after irradiationHodgkin lymphoma survivors have more severe coronary artery disease 20 years after chest irradiation, according to...